He J, Li C, Lee H, Shin D, Chern Y, Pereira De Carvalho B, et al. MIG-6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple-negative breast cancer. EMBO Rep. 2021;22:e50781 pubmed publisher

González Menéndez P, Hevia D, Alonso Arias R, Alvarez Artime A, Rodriguez Garcia A, Kinet S, et al. GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress. Redox Biol. 2018;17:112-127 pubmed publisher

Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher

Kuang R, Jahangiri A, Mascharak S, Nguyen A, Chandra A, Flanigan P, et al. GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance. JCI Insight. 2017;2:e88815 pubmed publisher

Mi Y, Geng G, Zou Z, Gao J, Luo X, Liu Y, et al. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells. PLoS ONE. 2015;10:e0120426 pubmed publisher

Takanaga H, Frommer W. Facilitative plasma membrane transporters function during ER transit. FASEB J. 2010;24:2849-58 pubmed publisher